Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiguo Hu

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The American Journal of Pathology|January 17, 2026
Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous LeukemiaNing Li, Yunyu Feng, Nan Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 26, 2018
SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell LinesWei Yan, Tao Yang, Jianhong Yang, et al.
Nature Genetics|July 17, 2012
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cellsHaojian Zhang, Cong Peng, Yiguo Hu, et al.
Theranostics|April 17, 2026
Cholesterol sulfate replenishment rejuvenates aged hematopoietic stem cell phenomesYunyu Feng, Ning Li, Nan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinomaLingyun Zhou, Linye He, Chang-Hai Liu, et al.
International Journal of Biological Sciences|April 13, 2022
The suppressive functions of Rora in B lineage cell proliferation and BCR/ABL1-induced B-ALL pathogenesisNing Li, Nan Wang, Wei He, et al.
Blood|July 24, 2010
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Ender Soydan, et al.
Molecular Cancer Therapeutics|April 4, 2018
SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting MicrotubulesFang Wang, Li Zheng, Yuyao Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple MyelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The American Journal of Pathology|January 17, 2026
Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous LeukemiaNing Li, Yunyu Feng, Nan Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 26, 2018
SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell LinesWei Yan, Tao Yang, Jianhong Yang, et al.
Nature Genetics|July 17, 2012
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cellsHaojian Zhang, Cong Peng, Yiguo Hu, et al.
Theranostics|April 17, 2026
Cholesterol sulfate replenishment rejuvenates aged hematopoietic stem cell phenomesYunyu Feng, Ning Li, Nan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinomaLingyun Zhou, Linye He, Chang-Hai Liu, et al.
International Journal of Biological Sciences|April 13, 2022
The suppressive functions of Rora in B lineage cell proliferation and BCR/ABL1-induced B-ALL pathogenesisNing Li, Nan Wang, Wei He, et al.
Blood|July 24, 2010
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Ender Soydan, et al.
Molecular Cancer Therapeutics|April 4, 2018
SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting MicrotubulesFang Wang, Li Zheng, Yuyao Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple MyelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.
Pageof 6